A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Financial Summary
| Share Statistics | TCGGY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,234.0 | $3,692.2 | 61% |
|
| Shares Out (Mil) | 15.3 | 98.2 | 26% |
|
| Institutional Ownership | 49.6% | 89.0% | 24% |
|
| Float (Mil) | 12.3 | 69.9 | 22% |
|
| Beta | 1.08 | 1.19 | 65% |
|
| Avg Daily Volume (000s) | 1 | 797 | 4% |
|
| Price Change (52-week) |
na | 86.1% | na |
|
| Growth | TCGGY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 6.1% | 7.7% | 42% |
|
| Net Income (5yr) | (26.1%) | (12.1%) | 16% |
|
| EPS (5yr) | (25.6%) | 2.1% | 10 |
|
| Dividends (5yr) | 7.8% | 0.0% | 96% |
|
| Cash Flow (5yr) | 16.8% | (14.9%) | 76% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | TCGGY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,077 | $810 | 51% |
|
| Net Income (TTM) (Mil) | ($144) | ($31) | 9% |
|
| EPS (TTM) | ($11.511) | ($0.300) | 4% |
|
| Operating Cash Flow (TTM) (Mil) | $118 | $56 | 53% |
|
| Net Cash Flow (TTM) (Mil) | ($164) | $3 | 11% |
|
| Long-Term Debt (Q1) (Mil) | $252 | $252 | 52% |
|
| Enterprise Value (Q1) (Mil) | $2,771 | $3,264 | 53% |
|
| Valuation | TCGGY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.71 | na |
|
| P/E | na | 41.4 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 5.9 | na |
|
| Ratios | TCGGY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 34.1% | 47.6% | 41% |
|
| Net Margin | (13.4%) | (4.6%) | 19% |
|
| ROA | (6.4%) | (4.7%) | 28% |
|
| ROE | (9.6%) | (7.7%) | 28% |
|
| Liabilities to Assets | 32.2% | 41.1% | 23% |
|
| F-Score | na | 5 | na |
|
Tecan Group AG did not pass any screens on 9/16/2026.
